First‐trimester screening identifies maternal cardiac maladaptation in midgestation

Documenti analoghi

• Comparison of competing‐risks model with angiogenic factors in midgestation screening for preterm growth‐related neonatal morbidity
  di: I. Papastefanou, et al.
  Pubblicazione: (2024)
• Association of maternal body mass index with hemodynamic and vascular alterations at 35–37 weeks' gestation
  di: M. Charakida, et al.
  Pubblicazione: (2025)
• Screening for pre‐eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation
  di: N. Sokratous, et al.
  Pubblicazione: (2024)
• Association of fetal growth restriction and stillbirth in twin compared with singleton pregnancies
  di: A. Syngelaki, et al.
  Pubblicazione: (2024)
• Maternal vascular indices and hemodynamic parameters at 36 weeks' gestation in gestational and pre‐existing diabetes mellitus
  di: A. Szczepkowska, et al.
  Pubblicazione: (2024)